De la infección tuberculosa al carcinoma escamoso pulmonar: un análisis de la respuesta inmune y la carcinogénesis

Stadler J. Updated WHO definitions for tuberculosis outcomes: Simplified, unified and future-proofed. Afr J Thorac Crit Care Med. 2022;28(2). PMID: 35919922.

Bi K, Zhao Y, Lu S, Xu K, Zhang Y. Comments on the WHO Global Tuberculosis Report 2024: progress, challenges and innovations for achieving end TB strategy by 2035. Infect Microbes Dis. 2025;7(1):1-4. https://doi.org/10.1097/IM9.0000000000000169

Fang C, He X, Tang F, Wang Z, Pan C, Zhang Q, et al. Where lung cancer and tuberculosis intersect: recent advances. Front Immunol. 2025;16:1561719. https://doi.org/10.3389/fimmu.2025.1561719

Li S, Feng M, Wang F, Liu D, Li M, Dai J, et al. Mycobacterium tuberculosis infection may increase the degrees of malignancy in lung adenocarcinoma. Front Immunol. 2025;16:1537520. https://doi.org/10.3389/fimmu.2025.1537520

Price C, Nguyen A. Latent Tuberculosis.En: StatPearls. Florida, Estados Unidos: StatPearls Publishing; 2025. [citado 2025 ab. 15]. PMID: 38261712.

Silva C, Fernandes D, Braga A, Cavalcante G, Sortica V, Hutz M, et al. Investigation of genetic susceptibility to Mycobacterium tuberculosis (VDR and IL10 genes) in a population with a high level of substructure in the Brazilian Amazon region. Int J Infect Dis. 2020;98:447-53. https://doi.org/10.1016/j.ijid.2020.06.090

Barham M, Whatney W, Khayumbi J, Ongalo J, Sasser L, Campbell A, et al. Activation-induced marker expression identifies mycobacterium tuberculosis-specific CD4 T cells in a cytokine-independent manner in HIV-infected individuals with latent tuberculosis. Immunohorizons. 2020;4(10):573-84. https://doi.org/10.4049/immunohorizons.2000051

World Health Organization. Global tuberculosis report 2024 [internet]. Ginebra: WHO; 2024 [citado 2025 my. 15]. Disponible en: https://iris.who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf?sequence=1

Zhang L, Rao Z. Structural biology and inhibition of the Mtb cell wall glycoconjugates biosynthesis on the membrane. Curr Opin Struct Biol. 2023;82:102670. https://doi.org/10.1016/j.sbi.2023.102670

Murray P, Rosenthal K, Pfaller M. Microbiología médica. España: Elsevier; 2021.

Kanabalan R, Lee L, Lee T, Chong P, Hassan L, Ismail R, et al. Human tuberculosis and Mycobacterium tuberculosis complex: a review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery. Microbiol Res. 2021;246:126674. https://doi.org/10.1016/J.MICRES.2020.126674

Bespiatykh D, Bespyatykh J, Mokrousov I, Shitikov E. A comprehensive map of Mycobacterium tuberculosis complex regions of difference. mSphere. 2021;6(4):e0053521. https://doi.org/10.1128/msphere.00535-21

Koleske B, Jacobs W, Bishai W. The Mycobacterium tuberculosis genome at 25 years: lessons and lingering questions. J Clin Invest. 2023;133(19):e173156. https://doi.org/10.1172/jci173156

Holzheimer M, Buter J, Minnaard A. Chemical synthesis of cell wall constituents of Mycobacterium tuberculosis. Chem Rev. 2021;121(15):9554-643. https://doi.org/10.1021/acs.chemrev.1c00043

Yang J, Zhang L, Qiao W, Luo Y. Mycobacterium tuberculosis: pathogenesis and therapeutic targets. MedComm. 2023;4(5):e353. https://doi.org/10.1002/mco2.353

Torrelles J, Chatterjee D. Collected thoughts on Mycobacterial Lipoarabinomannan, a cell envelope lipoglycan. Pathogens. 2023;12(11):1281. https://doi.org/10.3390/pathogens12111281

Mohammadnabi N, Shamseddin J, Emadi M, Bodaghi A, Varseh M, Shariati A, et al. Mycobacterium tuberculosis: the mechanism of pathogenicity, immune responses, and diagnostic challenges. J Clin Lab Anal. 2024;38(23):e25122. https://doi.org/10.1002/jcla.25122

Sarkar S, Mishra A, Periasamy S, Dyett B, Dogra P, Ball A, et al. Prospective subunit nanovaccine against Mycobacterium tuberculosis infection─cubosome lipid nanocarriers of cord factor, Trehalose 6,6′ Dimycolate. ACS Appl Mater Interfaces. 2023;15(23):27670-86. https://doi.org/10.1021/acsami.3c04063

Li M, Zhang Q, Wang Y, Xie J, Liang T, Liu Z, et al. From adhesion to invasion: the multifaceted roles of Mycobacterium tuberculosis lipoproteins. J Drug Target. 2025;33(7):1088-97. https://doi.org/10.1080/1061186x.2025.2472208

Ramon-Luing L, Palacios Y, Ruiz A, Téllez-Navarrete N, Chavez-Galan L. Virulence factors of Mycobacterium tuberculosis as modulators of cell death mechanisms. Pathogens. 2023;12(6):839. https://doi.org/10.3390/pathogens12060839

UniProt. Cell surface glycolipoprotein MPT83 [internet]. Uniprot. [citado 2025 my. 15]. Disponible en: https://www.uniprot.org/uniprotkb/P9WNF3/entry

Hu W, Spaink H. The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target. Biology. 2022;11(2):246. https://doi.org/10.3390/biology11020246

Rahlwes K, Dias B, Campos P, Alvarez-Arguedas S, Shiloh M. Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence. 2023;14(1):2150449. https://doi.org/10.1080/21505594.2022.2150449

Rivera-Calzada A, Famelis N, Llorca O, Geibel S. Type VII secretion systems: structure, functions and transport models. Nat Rev Microbiol. 2021;19(9):567-84. https://doi.org/10.1038/s41579-021-00560-5

Famelis N, Geibel S, van Tol D. Mycobacterial type VII secretion systems. Biol Chem. 2023;404(7):691-702. https://doi.org/10.1515/hsz-2022-0350

Abbas A, Lichtman A, Pillai S. Inmunología celular y molecular. 10.a ed. Elsevier; 2022.

Decout A, Katz J, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548-69. https://doi.org/10.1038/s41577-021-00524-z

Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3(12):1452-63. https://doi.org/10.1038/s43018-022-00468-w

Elemam N, Ramakrishnan R, Hundt J, Halwani R, Maghazachi A, Hamid Q. Innate lymphoid cells and natural killer cells in bacterial infections: function, dysregulation, and therapeutic targets. Front Cell Infect Microbiol. 2021;11:733564. https://doi.org/10.3389/fcimb.2021.733564

Liu D, Wang J, Xu Z, Chen X, Jiao X. Phagocytosis: strategies for macrophages to hunt Mycobacterium tuberculosis. One Health Advances. 2024;2(1):32. https://doi.org/10.1186/S44280-024-00065-9

Zihad S, Sifat N, Islam M, Monjur-Al-Hossain A, Sikdar K, Sarker M, et al. Role of pattern recognition receptors in sensing Mycobacterium tuberculosis. Heliyon. 2023;9(10):e20636. https://doi.org/10.1016/j.heliyon.2023.e20636

Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53. https://doi.org/10.1038/s41392-024-01757-9

Martínez-Limón A, Joaquin M, Caballero M, Posas F, de Nadal E. The p38 pathway: from biology to cancer therapy. Int J Mol Sci. 2020;21(6):1913. https://doi.org/10.3390/ijms21061913

Bhosale P, Kim H, Abusaliya A, Vetrivel P, Ha S, Park M, et al. Structural and functional properties of activator protein-1 in cancer and inflammation. Evid Based Complement Alternat Med. 2022;2022:9797929. https://doi.org/10.1155/2022/9797929

Yuan W, Song C. The emerging role of Rab5 in membrane receptor trafficking and signaling pathways. Biochem Res Int. 2020:4186308. https://doi.org/10.1155/2020/4186308

Bao Y, Wang L, Sun J. A small protein but with diverse roles: a review of EsxA in Mycobacterium-host interaction. Cells. 2021;10(7):1645. https://doi.org/10.3390/cells10071645

Xander C, Rajagopalan S, Jacobs W, Braunstein M. The SapM phosphatase can arrest phagosome maturation in an ESX-1 independent manner in Mycobacterium tuberculosis and BCG. Infect Immun. 2024;92(7):e0021724. https://doi.org/10.1128/iai.00217-24

Swiss-Model Repository. Mycobacterium tuberculosis low molecular weight protein-tyrosine phosphatase A (P9WIA1) [internet]. Suiza: Schwede Group; 2025 [citado 2025 my. 15]. Disponible en: https://swissmodel.expasy.org/repository/uniprot/P9WIA1

Chandra P, Grigsby S, Philips J. Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022;20(12):750-66. https://doi.org/10.1038/s41579-022-00763-4

Rojas W, Anaya J, Cano L, Luz A, Aristizábal B, Gómez L, et al. Inmunología de Rojas. 17.a ed. Medellín: Corporación para Investigaciones Biológicas; 2015.

Luo M, Xu X, Liu X, Shen W, Yang L, Zhu Z, et al. The non-receptor protein Tyrosine Phosphatase PTPN6 mediates a positive regulatory approach from the interferon regulatory factor to the JAK/STAT pathway in Litopenaeus vannamei. Front Immunol. 2022;13:913955. https://doi.org/10.3389/fimmu.2022.913955

Pardella E, Pranzini E, Leo A, Taddei M, Paoli P, Raugei G. Oncogenic tyrosine phosphatases: novel therapeutic targets for melanoma treatment. Cancers. 2020;12(10):2799. https://doi.org/10.3390/cancers12102799

Alsayed S, Gunosewoyo H. Combating tuberculosis via restoring the host immune capacity by targeting M. tb kinases and phosphatases. Int J Mol Sci. 2024;25(22):12481. https://doi.org/10.3390/ijms252212481

Margenat M, Betancour G, Irving V, Costábile A, García-Cedrés T, Portela M, et al. Characteristics of Mycobacterium tuberculosis PtpA interaction and activity on the alpha subunit of human mitochondrial trifunctional protein, a key enzyme of lipid metabolism. Front Cell Infect Microbiol. 2023;13:1095060. https://doi.org/10.3389/fcimb.2023.1095060

Ruddraraju K, Aggarwal D, Zhang Z. Therapeutic targeting of protein tyrosine phosphatases from Mycobacterium tuberculosis. Microorganisms. 2020;9(1):14. https://doi.org/10.3390/microorganisms9010014

UniProt. Triple specificity protein phosphatase [internet]. UniProt. [citado 2025 my. 15]. Disponible en: https://www.uniprot.org/uniprotkb/I6WXK4/entry

Yang H, Lei X, Chai S, Su G, Du L. From pathogenesis to antigens: the key to shaping the future of TB vaccines. Front Immunol. 2024;15:1440935. https://doi.org/10.3389/fimmu.2024.1440935

Basumallik N, Agarwal M. Small cell lung cancer [internet]. En StatPearls. Florida: Estados Unidos: StatPearls Publishing; 2023. [citado 2025 ab. 20]. PMID: 29494065.

Instituto Nacional del Cáncer. Tratamiento del cáncer de pulmón de células no pequeñas (PDQ®) –Versión para pacientes [internet]. Instituto Nacional del Cáncer; 2025 [citado 2025 my. 15]. Disponible en: https://www.cancer.gov/espanol/tipos/pulmon/paciente/tratamiento-pulmon-celulas-no-pequenas-pdq

Hashimoto A, Kawasaki Y, Tominaga A, Kakutani T, Kodama K, Nogi S, et al. Squamous cell lung cancer: methotrexate withdrawal induced spontaneous regression of liver metastases. J Clin Rheumatol. 2020;26(5):e137. https://doi.org/10.1097/rhu.0000000000001010

Siddiqui F, Vaqar S, Siddiqui A. Lung cancer [internet]. En: StatPearls. Florida, Estados Unidos: StatPearls Publishing; 2025. [citado 2025 ab. 20]. PMID: 29493979.

Berezowska S, Maillard M, Keyter M, Bisig B. Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis. Histopathology. 2024;84(1):32-49. https://doi.org/10.1111/his.15076

UniProt. Low molecular weight protein-tyrosine phosphatase A [internet]. UniProt [citado 2025 my. 15]. Disponible en: https://www.uniprot.org/uniprotkb/P9WIA1/entry

Qin Y, Chen Y, Chen J, Xu K, Xu F, Shi J. The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future. Infect Agents Cancer. 2022;17(1):20. https://doi.org/10.1186/s13027-022-00434-2

Luczynski P, Poulin P, Romanowski K, Johnston J. Tuberculosis and risk of cancer: a systematic review and meta-analysis. PLoS One. 2022;17(12):e0278661. https://doi.org/10.1371/journal.pone.0278661

Moon S, Choi H, Kim S, Kang H, Park D, Jung J, et al. Increased lung cancer risk and associated risk factors in tuberculosis survivors: a Korean population-based study. Clin Infect Dis. 2023;77(9):1329-39. https://doi.org/10.1093/cid/ciad373

Roy D, Ehtesham N, Hasnain S. Is Mycobacterium tuberculosis carcinogenic to humans? FASEB J. 2021;35(9):e21853. https://doi.org/10.1096/fj.202001581rr